Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients
Author Information
Author(s): Güth U, Huang D J, Schötzau A, Zanetti-Dällenbach R, Holzgreve W, Bitzer J, Wight E
Primary Institution: University Hospital Basel
Hypothesis
What factors contribute to non-adherence to adjuvant endocrine therapy in postmenopausal women with invasive breast cancer?
Conclusion
The study found that non-adherence to adjuvant endocrine therapy can be significantly reduced to 10.8% when patients are cared for by a specialized oncologic unit.
Supporting Evidence
- 66.6% of patients who initiated therapy completed it.
- 10.8% of patients showed non-adherence to therapy.
- Patients followed by a general practitioner were more likely to be non-adherent.
Takeaway
This study shows that when doctors focus on the needs of breast cancer patients, more of them stick to their treatment.
Methodology
The study analyzed data from 325 postmenopausal women diagnosed with HR-positive invasive breast cancer between 1997 and 2003, focusing on adherence to prescribed endocrine therapy.
Potential Biases
Potential bias due to reliance on patient self-reporting and the study being conducted in a single region.
Limitations
The study relies on self-reported adherence, which may not accurately reflect actual medication intake.
Participant Demographics
The mean age of participants was 67.3 years, with a range from 47 to 95 years.
Statistical Information
P-Value
0.0088
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website